QUILLICHEW Trademark

Trademark Overview

On Monday, July 13, 2015, a trademark application was filed for QUILLICHEW with the United States Patent and Trademark Office. The USPTO has given the QUILLICHEW trademark a serial number of 86690748. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, January 3, 2023. This trademark is owned by NextWave Pharmaceuticals, Inc.. The QUILLICHEW trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder
quillichew

General Information

Serial Number86690748
Word MarkQUILLICHEW
Filing DateMonday, July 13, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, January 3, 2023
Registration Number5115386
Registration DateTuesday, January 3, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 1, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of central nervous system diseases and disorders; Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 16, 2015
Primary Code005
First Use Anywhere DateMonday, April 18, 2016
First Use In Commerce DateMonday, April 18, 2016

Trademark Owner History

Party NameNextWave Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMonmouth Junction, NJ 08852
US
Party NameNextWave Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100175755
US
Party NameNextWave Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 100175755
US

Trademark Events

Event DateEvent Description
Thursday, July 16, 2015NEW APPLICATION ENTERED
Thursday, July 16, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 22, 2015ASSIGNED TO EXAMINER
Thursday, October 22, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 11, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 1, 2015PUBLISHED FOR OPPOSITION
Tuesday, December 1, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 26, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 21, 2016SOU TEAS EXTENSION RECEIVED
Thursday, July 21, 2016SOU EXTENSION 1 FILED
Thursday, July 21, 2016SOU EXTENSION 1 GRANTED
Saturday, July 23, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 9, 2016TEAS STATEMENT OF USE RECEIVED
Monday, November 28, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 9, 2016USE AMENDMENT FILED
Wednesday, November 30, 2016STATEMENT OF USE PROCESSING COMPLETE
Wednesday, November 30, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, December 1, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 3, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, October 3, 2018ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, February 5, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 5, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 3, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, June 17, 2022TEAS SECTION 8 & 15 RECEIVED
Tuesday, January 3, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, January 3, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, January 3, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, March 7, 2026COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

quillichew treatment preparations pharmaceutical deficit disorder attention hyperactivity system central nervous